drugset
Drugs / D,L-methadone
last change Dec 2025 re-read 3 minutes ago

D,L-methadone

also known as D,L-methadone hydrochloride · Methasan
Developed for
colorectal cancer
Investigated by
AIO-Studien-gGmbH · Deutsche Krebshilfe e.V., Bonn (Germany)

Trials 1

today NCT05212012 · Ph 1/2
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT05212012 Feb 2022 → Dec 2025 overdue colorectal cancer AIO-Studien-gGmbH Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as D,L-methadone ClinicalTrials.gov intervention name — accepted as the source's own label NCT05212012 ↗
Known as D,L-methadone hydrochloride “Dose Level D,L-methadone hydrochloride (Methasan® 10 mg/ml)” NCT05212012 ↗
Known as Methasan “Dose Level D,L-methadone hydrochloride (Methasan® 10 mg/ml)” NCT05212012 ↗